- Home
- FXNC vs MNPR Comparison
FXNC vs MNPR Comparison
Compare FXNC & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- MNPR
- Stock Information
- Founded
- FXNC 1907
- MNPR 2014
- Country
- FXNC United States
- MNPR United States
- Employees
- FXNC N/A
- MNPR N/A
- Industry
- FXNC Major Banks
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- MNPR Health Care
- Exchange
- FXNC Nasdaq
- MNPR Nasdaq
- Market Cap
- FXNC 175.2M
- MNPR 209.3M
- IPO Year
- FXNC N/A
- MNPR 2019
- Fundamental
- Price
- FXNC $20.57
- MNPR $34.60
- Analyst Decision
- FXNC Strong Buy
- MNPR Strong Buy
- Analyst Count
- FXNC 1
- MNPR 6
- Target Price
- FXNC $21.00
- MNPR $59.60
- AVG Volume (30 Days)
- FXNC 77.0K
- MNPR 54.2K
- Earning Date
- FXNC 07-30-2025
- MNPR 08-08-2025
- Dividend Yield
- FXNC 3.18%
- MNPR N/A
- EPS Growth
- FXNC N/A
- MNPR N/A
- EPS
- FXNC 0.70
- MNPR N/A
- Revenue
- FXNC $64,227,999.00
- MNPR N/A
- Revenue This Year
- FXNC $56.30
- MNPR N/A
- Revenue Next Year
- FXNC $5.74
- MNPR N/A
- P/E Ratio
- FXNC $27.75
- MNPR N/A
- Revenue Growth
- FXNC 31.73
- MNPR N/A
- 52 Week Low
- FXNC $15.00
- MNPR $1.72
- 52 Week High
- FXNC $26.97
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- FXNC 64.46
- MNPR 50.36
- Support Level
- FXNC $18.50
- MNPR $31.84
- Resistance Level
- FXNC $20.76
- MNPR $36.20
- Average True Range (ATR)
- FXNC 0.56
- MNPR 1.95
- MACD
- FXNC 0.22
- MNPR 0.27
- Stochastic Oscillator
- FXNC 92.24
- MNPR 68.26
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.